<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="methods-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Public Health</journal-id>
<journal-title>Frontiers in Public Health</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Public Health</abbrev-journal-title>
<issn pub-type="epub">2296-2565</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpubh.2025.1613903</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Public Health</subject>
<subj-group>
<subject>Community Case Study</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Adapting the deliberative democracy approach to LMIC settings: a case study in Nigeria</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Gaydos</surname>
<given-names>Laura M.</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2869861/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Salami</surname>
<given-names>Kabiru</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1237037/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yusuf</surname>
<given-names>Wasiu</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3203210/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Idigbe</surname>
<given-names>Ifeoma</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1275761/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Awolude</surname>
<given-names>Olutosin</given-names>
</name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2060016/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ogunsola</surname>
<given-names>Olabanjo</given-names>
</name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3153987/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Staple</surname>
<given-names>Tyree</given-names>
</name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3207277/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ezemelue</surname>
<given-names>Priscilla</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2369879/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ajayi</surname>
<given-names>Oluseye</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3137164/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ezechi</surname>
<given-names>Oliver</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/839329/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McBride</surname>
<given-names>Colleen M</given-names>
</name>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Flowers</surname>
<given-names>Lisa</given-names>
</name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3155445/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Health Policy and Management, Emory University</institution>, <addr-line>Atlanta, GA</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Sociology (Medical Sociology), University of Ibadan</institution>, <addr-line>Ibadan</addr-line>, <country>Nigeria</country></aff>
<aff id="aff3"><sup>3</sup><institution>Clinical Sciences Department, Nigerian Institute of Medical Research</institution>, <addr-line>Lagos</addr-line>, <country>Nigeria</country></aff>
<aff id="aff4"><sup>4</sup><institution>Obstetrics and Gynecology Department, College of Medicine, University of Ibadan</institution>, <addr-line>Ibadan</addr-line>, <country>Nigeria</country></aff>
<aff id="aff5"><sup>5</sup><institution>APIN Public Health Initiatives</institution>, <addr-line>Abuja, FCT</addr-line>, <country>Nigeria</country></aff>
<aff id="aff6"><sup>6</sup><institution>Department of Gynecology and Obstetrics, Emory University</institution>, <addr-line>Atlanta, GA</addr-line>, <country>United States</country></aff>
<aff id="aff7"><sup>7</sup><institution>Department of Behavioral, Social and Health Education Sciences, Emory University</institution>, <addr-line>Atlanta, GA</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001">
<p>Edited by: Morufu Olalekan Raimi, Federal University, Otuoke, Nigeria</p>
</fn>
<fn fn-type="edited-by" id="fn0002">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/580088/overview">Ngambouk Vitalis Pemunta</ext-link>, University of Gothenburg, Sweden</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2390134/overview">Ibrahim Dadari</ext-link>, United Nations Children&#x2019;s Fund, NYHQ, United States</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Laura M. Gaydos, <email>Laurie.gaydos@emory.edu</email>; Lisa Flowers, <email>Lflowe2@emory.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>10</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>13</volume>
<elocation-id>1613903</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>04</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>09</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Gaydos, Salami, Yusuf, Idigbe, Awolude, Ogunsola, Staple, Ezemelue, Ajayi, Ezechi, McBride and Flowers.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Gaydos, Salami, Yusuf, Idigbe, Awolude, Ogunsola, Staple, Ezemelue, Ajayi, Ezechi, McBride and Flowers</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec id="sec1">
<title>Background</title>
<p>Developing sustainable health promotion interventions in low- and middle-income countries (LMICs) faces challenges due to limited infrastructure and diverse cultural contexts. Community engagement is essential for effective health promotion, but higher intensity strategies may be infeasible in under-resourced settings. This study aimed to adapt the Mentor Mother (MM) HIV peer program to include HPV self-screening for Nigerian women living with HIV using deliberative democracy (DD) principles.</p>
</sec>
<sec id="sec2">
<title>Methods</title>
<p>The study utilized a tiered DD approach to explore stakeholders&#x2019; perspectives on feasible and sustainable strategies for the MM program. The process included two tiers: an initial deliberation among the research team and a subsequent community deliberation. The research team deliberation involved online sessions to identify feasible program adaptations as well as a model deliberation process. The community deliberation included a diverse group of stakeholders who participated in a two-day conference, engaging in small and large group discussions to reach consensus on program adaptations.</p>
</sec>
<sec id="sec3">
<title>Results</title>
<p>The research team identified two options for HPV sample collection and result delivery. The community deliberation reached consensus on both questions. For sample collection, the preferred option was for MMs to educate women in organized groups and transport samples to the laboratory. For result delivery, the consensus was for MMs to return all results to patients after additional training. The process demonstrated high levels of participant satisfaction, increased self-efficacy in explaining HPV screening, and adherence to DD principles of inclusivity, reasoned justification, and societal perspective.</p>
</sec>
<sec id="sec4">
<title>Conclusion</title>
<p>The DD process was feasible and effective in adapting the MM program for HPV screening in Nigeria. The approach empowered community members and enhanced the intervention&#x2019;s development. However, adaptations were necessary to address cultural norms and logistical challenges. The study highlights the potential of DD to inform health promotion strategies in LMICs, ensuring interventions are culturally appropriate and sustainable.</p>
</sec>
</abstract>
<kwd-group>
<kwd>deliberative democracy</kwd>
<kwd>LMIC</kwd>
<kwd>HIV</kwd>
<kwd>cervical cancer</kwd>
<kwd>HPV</kwd>
<kwd>women living with HIV</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="6"/>
<equation-count count="0"/>
<ref-count count="33"/>
<page-count count="11"/>
<word-count count="8879"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Public Health Education and Promotion</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec5">
<label>1</label>
<title>Introduction</title>
<p>Developing sustainable population-based health promotion interventions in low and middle-income countries (LMICs) faces numerous challenges. The infrastructure to sustain effective interventions is often lacking and rural communities are widely dispersed in ways that impede dissemination of these programs (<xref ref-type="bibr" rid="ref1">1</xref>, <xref ref-type="bibr" rid="ref2">2</xref>). LMIC settings are also culturally, linguistically, and religiously diverse. Moreover, many health promotion endeavors are developed in partnership with non-government organizations (NGOs) funded by high-income countries with variable cultural literacy. Effective health promotion strategies in LMICs must therefore be context-specific, community-informed, and responsive to local realities (<xref ref-type="bibr" rid="ref3">3</xref>, <xref ref-type="bibr" rid="ref4">4</xref>).</p>
<p>Community-based approaches that center peer engagement&#x2014;such as the Mentor Mother (MM) model&#x2014;have demonstrated success in improving health outcomes among women living with HIV (WLWH) (<xref ref-type="bibr" rid="ref5">5</xref>, <xref ref-type="bibr" rid="ref6">6</xref>). Integrating such models with services like cervical cancer (CC) screening is particularly important for WLWH, who face elevated risks of persistent Human Papilloma Virus (HPV) infection and CC (<xref ref-type="bibr" rid="ref7">7</xref>, <xref ref-type="bibr" rid="ref8">8</xref>). The World Health Organization (WHO) now recommends targeted screening and prevention strategies, including self-collection for HPV testing, which is both acceptable and feasible in many LMIC settings (<xref ref-type="bibr" rid="ref9">9</xref>, <xref ref-type="bibr" rid="ref10">10</xref>). Nonetheless, barriers such as stigma, limited infrastructure, and fragmented services continue to hinder integration (<xref ref-type="bibr" rid="ref11">11</xref>, <xref ref-type="bibr" rid="ref12">12</xref>). Despite the high burden of CC, HPV screening coverage in Nigeria remains low, with studies reporting rates as low as 8.3% among eligible women (<xref ref-type="bibr" rid="ref13">13</xref>).</p>
<p>Expanding access to HPV screening for WLWH is essential not only from a clinical standpoint but also from a health systems and equity perspective. The MM program presents a scalable and trusted platform for health communication and service delivery in Nigeria. MMs&#x2014;trained HIV-positive peers&#x2014;have built strong, trust-based relationships with the communities they serve, and their integration into CC screening efforts offers a pathway to increase uptake, ensure follow-through, and bridge service delivery gaps in under-resourced settings. Leveraging this model to include HPV screening capitalizes on existing infrastructure while aligning with national and global goals to reduce CC morbidity and mortality among high-risk populations.</p>
<p>In this context, community engagement strategies are considered standard practice if health promotion programs are to be effective and sustainable. Engagement strategies span a continuum, from lower-intensity forms like informing and consulting communities, to higher-intensity forms like community co-ownership (<xref ref-type="bibr" rid="ref14">14</xref>, <xref ref-type="bibr" rid="ref15">15</xref>). When health promotion collaborations include partners from high-income and LMIC settings, differences in cultural literacy and positionality underscore the need for more inclusive, participatory approaches to intervention design (<xref ref-type="bibr" rid="ref16">16</xref>).</p>
<p>Deliberative democracy (DD) is a promising high-intensity engagement framework that emphasizes structured dialog, the consideration of expert testimony, and inclusive participation to promote reasoned consensus (<xref ref-type="bibr" rid="ref17">17</xref>, <xref ref-type="bibr" rid="ref18">18</xref>). DD has gained traction in LMICs as a method to ensure legitimacy and community ownership in public health programs, with successful applications in priority-setting for HIV programs in Indonesia (<xref ref-type="bibr" rid="ref19">19</xref>), cancer prevention in South Africa (<xref ref-type="bibr" rid="ref20">20</xref>), and noncommunicable disease control in Kenya (<xref ref-type="bibr" rid="ref21">21</xref>). DD methods also enable marginalized groups to express their preferences and share experiential knowledge, potentially offsetting historic patterns of exclusion in global health research (<xref ref-type="bibr" rid="ref22">22</xref>).</p>
<p>Our large international and interdisciplinary team considered options for higher intensity engagement strategies to inform development of a sustainable program to increase access to HPV screening among WLWH. The research team comprised local NGOs, in-country academic institutions, and U. S.-based researchers. The goal was to adapt an existing HIV peer support program known as Mentor Mothers shown previously to be effective (<xref ref-type="bibr" rid="ref5">5</xref>, <xref ref-type="bibr" rid="ref6">6</xref>, <xref ref-type="bibr" rid="ref23">23</xref>, <xref ref-type="bibr" rid="ref24">24</xref>), to add HPV self-screening. Despite prior evidence supporting both peer-led and self-sampling approaches, few studies have examined how deliberative methods might inform program adaptations for WLWH in LMICs.</p>
<p>To this end, we decided to undertake a stakeholder engagement process based on principles of DD (<xref ref-type="bibr" rid="ref17">17</xref>, <xref ref-type="bibr" rid="ref25">25</xref>). DD is a structured deliberation process based on the assumption that priority setting is a value-based process (<xref ref-type="bibr" rid="ref26">26</xref>).</p>
<p>It brings together a diverse group of stakeholders&#x2014;including those directly affected by a health issue&#x2014;and equips them with balanced, factual information to enable reasoned dialog. Participants deliberate on competing values, weigh trade-offs, and work toward consensus solutions that are thought to promote the common good (<xref ref-type="bibr" rid="ref27">27</xref>). Deliberators are provided with neutral factual information about the issue via &#x201C;expert testimonies,&#x201D; encouraging them to air differing viewpoints, interests, and experiences in small and large group discussions. The deliberators then deliberate about the tradeoffs they view to be important to come to a consensus that, in theory, would maximize the common good. DD has been used in several international/LMIC settings for a number of different health and policy topics including noncommunicable disease control in Kenya (<xref ref-type="bibr" rid="ref21">21</xref>), HIV control in Indonesia (<xref ref-type="bibr" rid="ref19">19</xref>) and health priority setting (<xref ref-type="bibr" rid="ref22">22</xref>, <xref ref-type="bibr" rid="ref28">28</xref>, <xref ref-type="bibr" rid="ref29">29</xref>) and heritable human genome editing in South Africa (<xref ref-type="bibr" rid="ref20">20</xref>).</p>
<p>Arguably, this value-based process could be especially beneficial for understanding and sustaining health promotion programs in LMICs that have experienced the disempowering effects of historical colonialism (<xref ref-type="bibr" rid="ref30">30</xref>). Previous literature has found that DD methods provide more authentic public opinions (<xref ref-type="bibr" rid="ref16">16</xref>, <xref ref-type="bibr" rid="ref18">18</xref>, <xref ref-type="bibr" rid="ref31">31</xref>, <xref ref-type="bibr" rid="ref32">32</xref>). Enlisting communities in LMICs to generate and thoughtfully consider potential pros and cons of health policies and programs through the lens of personally experienced disparities can be an act of empowerment (<xref ref-type="bibr" rid="ref16">16</xref>). This focus on procedural fairness enables transparency in the decision-making process and how consensus is established, which are thought to increase the legitimacy of final decisions (<xref ref-type="bibr" rid="ref33">33</xref>).</p>
<p>Informed by previous research (<xref ref-type="bibr" rid="ref16">16</xref>, <xref ref-type="bibr" rid="ref28">28</xref>), we considered three key democratic principles that would suggest a quality deliberation process: <italic>Consideration of Balanced and Factual Information:</italic> DD requires that participants have basic and unbiased understanding of the issues and tradeoffs to enable active discussion of the questions being deliberated. <italic>Inclusivity:</italic> The deliberation group should reflect on the diversity of citizen and consumer views and life experiences. Deliberation cannot be fully democratic if participants do not have the opportunity to contribute. <italic>Deliberation:</italic> participants discuss and weigh differing, and often competing, social values to reach consensus as a group (<xref ref-type="bibr" rid="ref27">27</xref>). Members must have equal opportunity to take part in the discussion and deliberate, which involves listening and reflecting on others&#x2019; perspectives before reaching conclusions. Members are encouraged to adopt a societal perspective on the issue in question, where the deliberation focuses on what is best for society, rather than on what is best for individual participants. In addition, the group reflects on what they hear and provides their rationale when offering comments.</p>
<p>In our tiered DD process, we aimed to identify what the research team regarded as MM program adaptations that would be feasible and have the greatest potential to be sustainable in these geographically dispersed settings. In the second step, we presented these options in the form of deliberation questions and expert testimonies to assist deliberators to decide on which options to pursue. In this report, we describe our findings relating to the feasibility of conducting a quality deliberation process in an LMIC setting to arrive at our intervention adaptations.</p>
</sec>
<sec sec-type="materials|methods" id="sec6">
<label>2</label>
<title>Materials and methods</title>
<sec id="sec7">
<label>2.1</label>
<title>Overview</title>
<p>The DD approach was utilized to explore stakeholders&#x2019; perspectives on feasible and sustainable strategies for adopting the MM program to increase access to HPV screening among Nigerian WLWH.</p>
<p>DD is generally conducted as a single deliberation conference that includes stakeholders and citizens representing multiple constituencies and perspectives. Because this activity was to be conducted by study collaborators encompassing a new collaboration with a large interdisciplinary and multi-cultural team who were unfamiliar with the DD methods, we elected to conduct an initial deliberation among the research team.</p>
<p><xref ref-type="fig" rid="fig1">Figure 1</xref> shows the addition of the tier 1 research team deliberation to standard DD methods.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Adaptation of deliberative democracy approach.</p>
</caption>
<graphic xlink:href="fpubh-13-1613903-g001.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Flowchart outlines a deliberation process with three main sections: Key Democratic Principles, Internal Team Deliberation Process, and Community Deliberation Process. Key Democratic Principles include inclusivity, balanced information, and deliberation with four subpoints. Both deliberation processes have three steps: Information Phase, Deliberation Phase, and Consensus Phase. The Internal Team focuses on expert presentations and feasibility, while the Community Process emphasizes social, cultural, communal, individual, and group values. Adapted from Guan et al. 2022.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec8">
<label>2.2</label>
<title>Positionality statement</title>
<p>Prior to commencing our research team deliberation, it was incumbent upon our team to acknowledge our positionality. Our research team comprises collaborators from an American university, a Nigerian university, a Nigerian research institute, and a Nigerian non-governmental organization (NGO). As a transnational, interdisciplinary group, we recognize that our varied institutional affiliations, professional roles, and personal identities shape our approach to research and community engagement.</p>
<p>Team members based at a large academic medical center and university in the United States bring expertise in DD, public health policy, gynecology, and behavioral sciences. The American collaborators acknowledge that our positioning within a high-income country and Western academic framework confers privileges that may influence research priorities, access to funding, and the interpretation of data. We remain conscious of the potential for power imbalances in global health collaborations and are committed to practices that promote equity, shared leadership, and local relevance.</p>
<p>Our Nigerian collaborators&#x2014;clinicians, social scientists, and public health experts&#x2014;are deeply embedded in the healthcare and sociocultural contexts of the communities we study. Their longstanding work with WLWH, including through the MM program, provides the critical on-the-ground perspective needed to ensure that our research is culturally grounded, ethically sound, and practically feasible. Their contributions were central to adapting the DD framework to the Nigerian context and to guiding community-engaged methodologies that respected local norms and priorities.</p>
<p>We acknowledge the ongoing structural inequities in global health research and therefore, intentionally engaged in a co-learning process, including internal deliberation sessions among the research team, to reflect on our positionalities and collectively shape study design and implementation. Our team aimed to create a research process that was collaborative, respectful, and responsive to community voices, especially those of WLWH, whose lived experiences are central to our study.</p>
</sec>
<sec id="sec9">
<label>2.3</label>
<title>Tier 1: research team deliberation</title>
<p>In the first 6&#x202F;months of the funding period, the principal investigators and co-investigators on the project engaged in 24&#x202F;h of online sessions that mimicked the planned deliberation process to be conducted with community constituencies. The research team deliberation was facilitated by a co-Investigator with expertise in DD (CM) and comprised eight investigators with expertise that included: DD methods, implementation science, CC prevention and treatment, and HIV/AIDS prevention and treatment. The research team deliberation was guided by the overarching question, <italic>what adaptations to the Mentor Mother program would be feasible and sustainable in the target settings that could be prioritized by recruited deliberators?</italic> We then decided on two more specific deliberation questions driven by areas for which our own research team was not in agreement: Question (1) <italic>What is the approach for collecting HPV samples for women who are HIV+ that best balances benefits and challenges?</italic> And Question (2) <italic>What is the approach for returning results to women who are screened for HPV that best balances the benefits and challenges?</italic></p>
<p>Investigator-led, co-learning presentations were used as expert testimonies to give the research team a shared understanding of the pros and cons of different program adaptations for the sustainability of the adapted MM intervention. Expert testimony topics included: DD methodology, CC and HPV screening, steps involved in self-collection of biological samples, and the MM program. Questions were addressed and discussions initiated among the research team.</p>
<p>After the presentations, researchers identified the pros and cons of different locations for MM&#x2019;s to educate women and to conduct self-testing. A second deliberation followed a similar process for discussing the role of MM in delivering HPV screening results. Research team members broke into small groups as would be done in a formal deliberation, discussed the pros and cons of possible approaches, came to consensus and presented their rationale for the approach they favored to the larger team for further discussion.</p>
<p>The team deliberations resulted in two options for each of the deliberation questions. For question 1: <italic>What is the approach for collecting HPV samples for women who are HIV+ that best balances benefits and challenges?</italic> our team developed two options: the first option was for MMs to visit women in their homes to educate and facilitate home-based self-collection and for women to transport their own samples to local clinics for analysis. The second option was for MMs to educate women as a group about CC self-screening and provide screening kits in designated meeting locations with MMs transporting samples back to the laboratory or clinic.</p>
<p>For question 2: <italic>What is the approach for returning results to women who are screened for HPV that best balances the benefits and challenges?</italic> the first option was for MMs to notify women of normal/negative results with local nurses contacting women who had positive screening results. The second option was to provide MMs with additional training in how to return all results (both positive and negative) to patients. The final deliberation questions and options that were agreed upon after the team deliberation represented areas in which the experts on our research team held disagreements about the best approach for the intervention.</p>
</sec>
<sec id="sec10">
<label>2.4</label>
<title>Tier 2: stakeholder deliberations for the community</title>
<sec id="sec11">
<label>2.4.1</label>
<title>Recruitment for the community deliberation</title>
<p>The research team developed a recruitment rubric intended to maximize the likelihood that a diverse group of stakeholders and members of the general public would be represented at the deliberation conference. Additionally, the team sought to include a diverse group of participants based on demographic factors including gender, age, and state (with a balance from the northern and southern regions of the country) (see <xref ref-type="table" rid="tab4">Table 4</xref> for diversity of actual deliberation participants). The research team developed a comprehensive list of potential deliberators that included representatives from NGOs associated with the MMs program, seasoned mentor mothers, WLWH, and nurses in community clinics. Community members not affected by HIV also were suggested as representatives of the general public. Ten key perspectives were identified as shown in <xref ref-type="table" rid="tab1">Table 1</xref>.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Perspectives sought for deliberation.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Perspective</th>
<th align="left" valign="top">Justification for inclusion</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Association of women living with HIV/AIDS in Nigeria (ASHWAN)</td>
<td align="left" valign="top">Nationally representative group advocating for WLWH</td>
</tr>
<tr>
<td align="left" valign="top">Clinic nurse managers</td>
<td align="left" valign="top">Will oversee intervention in clinic sites</td>
</tr>
<tr>
<td align="left" valign="top">Community members (not person living with HIV)</td>
<td align="left" valign="top">Outside perspective from someone not directly related to care for WLWH</td>
</tr>
<tr>
<td align="left" valign="top">Gynecologists</td>
<td align="left" valign="top">Will evaluate and treat WLWH found to have high-risk HPV</td>
</tr>
<tr>
<td align="left" valign="top">Husband or male family members of woman living with HIV</td>
<td align="left" valign="top">In many parts of Nigeria (especially the North) male family members determine behaviors of women</td>
</tr>
<tr>
<td align="left" valign="top">Journalists against AIDS</td>
<td align="left" valign="top">Advocate for the rights and wellbeing of people living with HIV</td>
</tr>
<tr>
<td align="left" valign="top">MMs in HIV program</td>
<td align="left" valign="top">MMs will be implementing the intervention</td>
</tr>
<tr>
<td align="left" valign="top">Laboratory coordinators (National/Regional)</td>
<td align="left" valign="top">Laboratory will be an important part of the intervention to ensure that samples are received and results are returned</td>
</tr>
<tr>
<td align="left" valign="top">Nurse/nurse counselors</td>
<td align="left" valign="top">Nurses currently return most HIV results</td>
</tr>
<tr>
<td align="left" valign="top">WLWH</td>
<td align="left" valign="top">The target population for the intervention</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Additionally, the goal was to include deliberators who would feel confident to express the views of their constituency in small and large group discussions. Based on these considerations and the research team&#x2019;s brainstorming, a list of 21 people was generated. A letter to each person was sent from one of our collaborating non-governmental institutions in Nigeria inviting them to participate in a two-day conference at the Nigerian Institute of Medical Research in Lagos, Nigeria.</p>
</sec>
<sec id="sec12">
<label>2.4.2</label>
<title>Materials development</title>
<p>Our team identified key content that would enable a shared understanding of issues related to HPV screening that would enable community participants to deliberate on our questions. The objective was to be as parsimonious as possible in identifying content as the expert testimonies had to be relatively short, if we were to contain the process to a two-day deliberation. We generated a list of 8 topics we considered essential background information and developed draft slide decks for each topic; slide decks were reviewed by the full research team and finalized. Each slide deck was turned into a video recording with a voiceover recorded by a Nigerian voice actor in English, which was selected given that all of the deliberation participants were expected to have moderate to good verbal English fluency. Video topics are shown in <xref ref-type="table" rid="tab2">Table 2</xref>. We also adapted in-depth workbooks from Guan et al.&#x2019;s previous study (<xref ref-type="bibr" rid="ref5">5</xref>) for the deliberators to use during the conference and a similar guide for deliberation facilitators to use during the conference. The workbooks were reviewed by Nigerian colleagues for cultural awareness and piloted with a group of three MMs who provided feedback and allowed us to revise them to be most useful and acceptable for the intervention.</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Community stakeholder deliberation video topics.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>Community stakeholder deliberation video topics</th>
<th align="left" valign="top">Video length</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Video 1: Introduction to the citizen deliberation process</td>
<td align="left" valign="top">6&#x202F;min</td>
</tr>
<tr>
<td align="left" valign="top">Video 2: Understanding population screening</td>
<td align="left" valign="top">4&#x202F;min</td>
</tr>
<tr>
<td align="left" valign="top">Video 3: Interaction between HIV, HPV and CC</td>
<td align="left" valign="top">3&#x202F;min</td>
</tr>
<tr>
<td align="left" valign="top">Video 4: HPV screening</td>
<td align="left" valign="top">3&#x202F;min</td>
</tr>
<tr>
<td align="left" valign="top">Video 5: Self-sampling for HPV screening</td>
<td align="left" valign="top">3&#x202F;min</td>
</tr>
<tr>
<td align="left" valign="top">Video 6: MMs and their role serving women living with HIV (WLWH)</td>
<td align="left" valign="top">3&#x202F;min</td>
</tr>
<tr>
<td align="left" valign="top">Video 7: Understanding HPV test results</td>
<td align="left" valign="top">2&#x202F;min</td>
</tr>
<tr>
<td align="left" valign="top">Video 8: Options for who should return HPV for WLWH</td>
<td align="left" valign="top">4&#x202F;min</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec13">
<label>2.4.3</label>
<title>Training of deliberation facilitators and scribes</title>
<p>Five Nigerian facilitators were recruited for the deliberations. The facilitators were experienced focus group facilitators who had worked with and were recruited by Nigerian research partners. Members of the team with expertise in DD conducted 4&#x202F;h of facilitation training (two, two-hour virtual sessions) in the weeks prior to the deliberation conference. The training consisted of mock deliberation sessions and walking through the facilitator manual in detail. We also conducted a &#x201C;mop up&#x201D; training the night before the deliberation conference in which two members of the research team reviewed the protocols, role played their specific parts and clarified any outstanding questions. In addition to the facilitators, four scribes (also women who had assisted our NGO partners in previous qualitative studies) participated in the &#x201C;mop up&#x201D; training during which they role played their roles in a mock deliberation. Logistic roles such as audio recording also were practiced during this session.</p>
</sec>
<sec id="sec14">
<label>2.4.4</label>
<title>Deliberation conference procedures</title>
<p>Our Deliberation conference consisted of a mix of educational sessions, small group and large group deliberations as shown in <xref ref-type="table" rid="tab3">Table 3</xref>.</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>Sequence and content of the DD conference.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top" colspan="2">Day 1</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">1st plenary session<break/>(2&#x202F;h)</td>
<td align="left" valign="top">
<list list-type="bullet">
<list-item>
<p>Overview and introductions</p>
</list-item>
<list-item>
<p>Overview of the CHESS project</p>
</list-item>
<list-item>
<p>Video presentation of the DD process and how it will direct the study implementation (Expert testimony #1)</p>
</list-item>
</list>
</td>
</tr>
<tr>
<td align="left" valign="top" colspan="2">Tea break (30&#x202F;min)</td>
</tr>
<tr>
<td align="left" valign="top">1st small group deliberations<break/>(45&#x202F;min)</td>
<td align="left" valign="top">
<list list-type="bullet">
<list-item>
<p>Mock deliberation and voting on humorous topic</p>
</list-item>
</list>
</td>
</tr>
<tr>
<td align="left" valign="top">2nd plenary session<break/>(80&#x202F;min)</td>
<td align="left" valign="top">
<list list-type="bullet">
<list-item>
<p>View expert testimony background videos</p>
</list-item>
<list-item>
<p>Understanding population screening (Expert testimony #2)</p>
</list-item>
<list-item>
<p>HIV, HPV and CC (Expert testimony #3)</p>
</list-item>
<list-item>
<p>HPV screening (Expert testimony #4)</p>
</list-item>
<list-item>
<p>Q&#x0026;A about the content in the videos</p>
</list-item>
<list-item>
<p>Watch more expert testimony background videos</p>
</list-item>
<list-item>
<p>Self-Sampling for HPV Screening (Expert testimony #5)</p>
</list-item>
<list-item>
<p>Mentor mothers and their role with WLWH (Expert testimony #6)</p>
</list-item>
<list-item>
<p>Q&#x0026;A about the content in the videos</p>
</list-item>
<list-item>
<p>Introduce deliberation question for day 1</p>
</list-item>
</list>
</td>
</tr>
<tr>
<td align="left" valign="top">2nd small group deliberations<break/>(45&#x202F;min)</td>
<td align="left" valign="top">
<list list-type="bullet">
<list-item>
<p>Deliberation and voting on best approach for collecting HrHPV samples from WLWH</p>
</list-item>
</list>
</td>
</tr>
<tr>
<td align="left" valign="top" colspan="2">Lunch (1&#x202F;h)</td>
</tr>
<tr>
<td align="left" valign="top">1st large group deliberation<break/>(75&#x202F;min)</td>
<td align="left" valign="top">
<list list-type="bullet">
<list-item>
<p>Breakout groups present deliberation pros and cons list to full group</p>
</list-item>
<list-item>
<p>Vote on deliberation question 1</p>
</list-item>
</list>
</td>
</tr>
<tr>
<td align="left" valign="top">Facilitator team debrief<break/>(30&#x202F;min)</td>
<td align="left" valign="top">
<list list-type="bullet">
<list-item>
<p>Facilitator team debrief with study investigators</p>
</list-item>
</list>
</td>
</tr>
</tbody>
</table>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top" colspan="2">Day 2</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">3rd plenary session<break/>(90&#x202F;min)</td>
<td align="left" valign="top">
<list list-type="bullet">
<list-item>
<p>Watch expert testimony background videos</p>
</list-item>
<list-item>
<p>Understanding HPV test results (Expert testimony #7)</p>
</list-item>
<list-item>
<p>Considerations for who should return HPV results for WLWH (Expert testimony # 8)</p>
</list-item>
<list-item>
<p>Q&#x0026;A about the content in the videos</p>
</list-item>
<list-item>
<p>Introduce deliberation question for day 2</p>
</list-item>
</list>
</td>
</tr>
<tr>
<td align="left" valign="top">3rd small group deliberations<break/>(75&#x202F;min)</td>
<td align="left" valign="top">
<list list-type="bullet">
<list-item>
<p>Deliberation and voting on best approach for returning HPV test results to WLWH</p>
</list-item>
</list>
</td>
</tr>
<tr>
<td align="left" valign="top" colspan="2">Lunch (1&#x202F;h)</td>
</tr>
<tr>
<td align="left" valign="top">2nd large group deliberation<break/>(75&#x202F;min)</td>
<td align="left" valign="top">
<list list-type="bullet">
<list-item>
<p>Breakout groups present deliberation pros and cons list to full group</p>
</list-item>
<list-item>
<p>Vote on deliberation question 2</p>
</list-item>
</list>
</td>
</tr>
<tr>
<td align="left" valign="top">Survey, evaluation and wrap up<break/>(30&#x202F;min)</td>
<td align="left" valign="top">
<list list-type="bullet">
<list-item>
<p>Participants complete evaluation surveys</p>
</list-item>
</list>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Day 1, deliberators checked in and completed a baseline survey assessing their knowledge of CC, self-screening, and HIV. Deliberators started with a mock deliberation on a humorous topic (i.e., choice of which of two silly hats to wear on a first date) to understand how the deliberation process worked as well as the consensus voting. In the morning and afternoon sessions, deliberators were asked to watch the expert testimony videos relevant to the day&#x2019;s deliberation question. The Day 1 question was<italic>: What is the approach for collecting HPV samples for women who are HIV+ that best balances benefits and challenges?</italic> After viewing the expert testimonies and offering an opportunity for follow-up questions, the participants were grouped into four heterogeneous (by role/perspective/geography) breakout groups of 5&#x2013;6 participants each. Initially, prior to any other discussion, each breakout group facilitator asked the deliberators to individually state their initial vote on the two presented options. Once these initial perspectives were shared, the deliberators worked in their small group to generate a comprehensive list of pros and cons for each option. After the pros/cons list was generated and the group agreed that the list was comprehensive, another round of voting was held in which each participant again voted and explained their rationale for the vote. Voting continued until an 80% consensus on the best option was reached. Once the small groups had achieved consensus, the deliberators reconvened as a large group. Each small group selected a representative to share their list of pros and cons, the results of their small group vote and the general rationale for the consensus. Small group representatives were asked to highlight points of agreement and disagreement and how they were able to reach (or not reach) consensus. At the end of the small group representative presentations, all participants were asked to take a large group vote on the two options. If 80% consensus was not reached, the group would discuss further and vote again.</p>
<p>The same process of small group discussions followed by large group deliberation was repeated for day 2 of the conference. For day 2, the deliberation question was: <italic>What is the approach for returning results to women who are screened for HPV that best balances the benefits and challenges?</italic> Upon completion of day 2 deliberation activities, the participants took the post-survey. This study has been approved by the Institutional Review Boards of Emory University (STUDY00004817), APIN Public Health Initiatives, the Nigerian Institute of Medical Research, and the University of Ibadan. All study participants will be consented to participate.</p>
</sec>
<sec id="sec15">
<label>2.4.5</label>
<title>Data collection</title>
<p>Quantitative data collection included consensus vote tallies at each stage of the deliberation and pre- and post-conference surveys to assess participant knowledge, attitudes and beliefs related to CC prevention for WLWH. We also assessed self-efficacy with questions about perceived confidence in the ability to explain to members of their community about various topics including HIV, CCrisk, and CC screening as well as statements about the importance of their views in informing government decision makers regarding CC prevention. The post survey also included satisfaction questions (e.g., do you feel that you were respected by your group members and how helpful they found each component of the process) and recommendations for the conference itself.</p>
<p>Qualitative data collection included audio recording and transcribing all conference sessions (small group and large group) verbatim. We also collected the pros and cons lists from each of the deliberators. No specific guides were used for the deliberation data collection beyond the presentation of two alternatives and the question of which one best balanced the strengths and challenges. This is consistent with standard DD implementation during which the participants generate the pros, cons, comments and questions rather than responding interview or focus group prompts.</p>
</sec>
<sec id="sec16">
<label>2.4.6</label>
<title>Quantitative data analysis</title>
<p>Quantitative data analysis of survey data was conducted using SPSS (<xref ref-type="bibr" rid="ref26">26</xref>) to characterize the participants&#x2019; demographics, ratings of their experience with deliberation and changes to self-efficacy. We compared pre and post survey scores for each individual as well as comparing pre and post means and significance testing for the group of all participants.</p>
</sec>
<sec id="sec17">
<label>2.4.7</label>
<title>Qualitative analysis</title>
<p>We coded deliberation session transcripts for the following indicators of process quality (<xref ref-type="bibr" rid="ref5">5</xref>, <xref ref-type="bibr" rid="ref27">27</xref>) <italic>speaking opportunities (inclusivity), adoption of a societal perspective on the issues in question (societal perspective) and reasoned justification of ideas (consideration of balanced and factual information)</italic>. With regards to <italic>speaking opportunities</italic>, we measured deliberation participation in terms of number of statements made in each small group and percentage of the comments made by each individual (using the total number of statements made by all participants as part of the same small deliberation group as the denominator). Notably, one set of facilitators (impacting 1 group each day) did not use names during the deliberation, making it impossible for us to count the participation for those groups. <italic>Adoption of a societal perspective</italic> was demonstrated when a participant made a statement related to the greater good/harm of an option on the population at large. <italic>Reasoned Justification</italic> of ideas was demonstrated when a participant used the expert testimony provided or considered the pros and cons of an option.</p>
<p>Coding of deliberation transcripts was completed using MAXQDA software (<xref ref-type="bibr" rid="ref28">28</xref>). We adapted a qualitative coding scheme used by others to examine the deliberation process (<xref ref-type="bibr" rid="ref27">27</xref>, <xref ref-type="bibr" rid="ref29">29</xref>). One study team member reviewed all transcripts and compared them to the audio recordings. Two study team members coded each transcript. Following initial independent coding, the two coders met with a larger group of investigators to review coding and discuss discrepancies. Additionally, the larger coding group compared themes in the initial coding to the comprehensive list of pros and cons, adding new themes and generating recommendations for adapting the CHESS Mentor Mother intervention.</p>
</sec>
</sec>
</sec>
<sec sec-type="results" id="sec18">
<label>3</label>
<title>Results</title>
<sec id="sec19">
<label>3.1</label>
<title>Community deliberators</title>
<p>Of the 10 perspectives prioritized in our recruitment rubric, we were able to capture 9 of the perspectives from 21 participants who varied in gender (70% female, 30% male), age, and state (the 8 states in which our study has clinic sites were all represented) as shown in <xref ref-type="table" rid="tab4">Table 4</xref> above. All 21 invitees responded to the invitation with 19 agreeing to attend and two requesting to send a proxy in their stead. All 21 scheduled participants showed up to day one and day two of the deliberation conference.</p>
<table-wrap position="float" id="tab4">
<label>Table 4</label>
<caption>
<p>Demographics of community deliberation participants.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Region</th>
<th align="left" valign="top">State</th>
<th align="left" valign="top">Gender</th>
<th align="center" valign="top">Age</th>
<th align="left" valign="top">Perspective</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Central</td>
<td align="left" valign="top">Abuja</td>
<td align="left" valign="top">Male</td>
<td align="center" valign="top">40s</td>
<td align="left" valign="top">Regional or national coordinator national sample referral network (Laboratory)</td>
</tr>
<tr>
<td align="left" valign="top">Central</td>
<td align="left" valign="top">Abuja</td>
<td align="left" valign="top">Female</td>
<td align="center" valign="top">30s</td>
<td align="left" valign="top">Association of women living HIV/AIDS in Nigeria (ASHWAN)</td>
</tr>
<tr>
<td align="left" valign="top">North central</td>
<td align="left" valign="top">Plateau</td>
<td align="left" valign="top">Female</td>
<td align="center" valign="top">50s</td>
<td align="left" valign="top">Clinic nurse manager</td>
</tr>
<tr>
<td align="left" valign="top">North central</td>
<td align="left" valign="top">Jos</td>
<td align="left" valign="top">Male</td>
<td align="center" valign="top">40s</td>
<td align="left" valign="top">Community member (non person living with HIV/AIDS)</td>
</tr>
<tr>
<td align="left" valign="top">North central</td>
<td align="left" valign="top">Plateau</td>
<td align="left" valign="top">Male</td>
<td align="center" valign="top">40s</td>
<td align="left" valign="top">Gynecologist</td>
</tr>
<tr>
<td align="left" valign="top">North central</td>
<td align="left" valign="top">Plateau</td>
<td align="left" valign="top">Female</td>
<td align="center" valign="top">40s</td>
<td align="left" valign="top">Nurse</td>
</tr>
<tr>
<td align="left" valign="top">North central</td>
<td align="left" valign="top">Plateau</td>
<td align="left" valign="top">Female</td>
<td align="center" valign="top">40s</td>
<td align="left" valign="top">Nurse/Nurse counselor</td>
</tr>
<tr>
<td align="left" valign="top">Northern</td>
<td align="left" valign="top">Kano</td>
<td align="left" valign="top">Male</td>
<td align="center" valign="top">50s</td>
<td align="left" valign="top">Gynecologist</td>
</tr>
<tr>
<td align="left" valign="top">Northern</td>
<td align="left" valign="top">Kano</td>
<td align="left" valign="top">Female</td>
<td align="center" valign="top">40s</td>
<td align="left" valign="top">Nurse/Nurse counselor</td>
</tr>
<tr>
<td align="left" valign="top">Northern</td>
<td align="left" valign="top">Kano</td>
<td align="left" valign="top">Female</td>
<td align="center" valign="top">40s</td>
<td align="left" valign="top">Woman living with HIV/ Mentor Mother</td>
</tr>
<tr>
<td align="left" valign="top">Southeastern</td>
<td align="left" valign="top">Anambra</td>
<td align="left" valign="top">Female</td>
<td align="center" valign="top">50s</td>
<td align="left" valign="top">Gynecologist</td>
</tr>
<tr>
<td align="left" valign="top">Southeastern</td>
<td align="left" valign="top">Anambra</td>
<td align="left" valign="top">Female</td>
<td align="center" valign="top">40s</td>
<td align="left" valign="top">Nurse/Nurse counselor</td>
</tr>
<tr>
<td align="left" valign="top">Southeastern</td>
<td align="left" valign="top">Anambra</td>
<td align="left" valign="top">Female</td>
<td align="center" valign="top">50s</td>
<td align="left" valign="top">Woman living with HIV/ Mentor Mother</td>
</tr>
<tr>
<td align="left" valign="top">Southern</td>
<td align="left" valign="top">Delta</td>
<td align="left" valign="top">Male</td>
<td align="center" valign="top">50s</td>
<td align="left" valign="top">Gynecologist</td>
</tr>
<tr>
<td align="left" valign="top">Southern</td>
<td align="left" valign="top">Delta</td>
<td align="left" valign="top">Female</td>
<td align="center" valign="top">30s</td>
<td align="left" valign="top">Nurse/Nurse counselor</td>
</tr>
<tr>
<td align="left" valign="top">Southern</td>
<td align="left" valign="top">Delta</td>
<td align="left" valign="top">Female</td>
<td align="center" valign="top">40s</td>
<td align="left" valign="top">Woman living with HIV/Mentor mother</td>
</tr>
<tr>
<td align="left" valign="top">Southwestern</td>
<td align="left" valign="top">Oyo</td>
<td align="left" valign="top">Female</td>
<td align="center" valign="top">40s</td>
<td align="left" valign="top">Woman living with HIV/Mentor mother</td>
</tr>
<tr>
<td align="left" valign="top">Southwestern</td>
<td align="left" valign="top">Oyo</td>
<td align="left" valign="top">Female</td>
<td align="center" valign="top">50s</td>
<td align="left" valign="top">Clinic nurse manager</td>
</tr>
<tr>
<td align="left" valign="top">Southwestern</td>
<td align="left" valign="top">Oyo</td>
<td align="left" valign="top">Female</td>
<td align="center" valign="top">40s</td>
<td align="left" valign="top">Gynecologist</td>
</tr>
<tr>
<td align="left" valign="top">Southwestern</td>
<td align="left" valign="top">Lagos</td>
<td align="left" valign="top">Female</td>
<td align="left" valign="top">Unknown</td>
<td align="left" valign="top">Journalist against AIDS</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec20">
<label>3.2</label>
<title>Satisfaction with the deliberation process</title>
<p>All 21 deliberators (100% completion rate) rated their satisfaction with the process to be very high (<xref ref-type="table" rid="tab5">Table 5</xref>). Ratings were particularly high for feeling respected by the group and feeling heard by the facilitator.</p>
<table-wrap position="float" id="tab5">
<label>Table 5</label>
<caption>
<p>Respondent satisfaction with the community deliberation (1&#x2013;10 scale).</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Question</th>
<th align="center" valign="top">Mean value</th>
<th align="center" valign="top">Range</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Do you feel that your opinions were respected by your group members?</td>
<td align="center" valign="top">9.7</td>
<td align="center" valign="top">8&#x2013;10</td>
</tr>
<tr>
<td align="left" valign="top">Do you feel you were listened to by your facilitator?</td>
<td align="center" valign="top">9.7</td>
<td align="center" valign="top">9&#x2013;10</td>
</tr>
<tr>
<td align="left" valign="top">Do you feel that the process that led to your group&#x2019;s final vote was fair?</td>
<td align="center" valign="top">9.2</td>
<td align="center" valign="top">4&#x2013;10</td>
</tr>
<tr>
<td align="left" valign="top">How willing were you to abide by the group&#x2019;s final vote, even if you personally have a different view?</td>
<td align="center" valign="top">8.8</td>
<td align="center" valign="top">6&#x2013;10</td>
</tr>
<tr>
<td align="left" valign="top">How much did attending the session change your understanding about CC screening in Nigeria?</td>
<td align="center" valign="top">9.3</td>
<td align="center" valign="top">3&#x2013;10</td>
</tr>
<tr>
<td align="left" valign="top">How much did attending the session change your opinion about CC screening in Nigeria?</td>
<td align="center" valign="top">8.9</td>
<td align="center" valign="top">1&#x2013;10</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec21">
<label>3.3</label>
<title>Self-efficacy related to HPV screening knowledge</title>
<p><xref ref-type="table" rid="tab6">Table 6</xref> shows pre- to post-deliberation changes in self-efficacy to explain to community members the concepts covered in the expert testimonies. Confidence (1-low to 5-high) to explain increased for all measures and this increase was statistically significant for 5 of the 9 measures. Increases were highest for deliberators with respect to explaining HPV self-testing to women with HIV, what a &#x201C;high-risk&#x201D; result means, and how often women need CC screening. Moreover, there were significant increases in indicators of feeling empowered by the process as indicated by increases in perceptions that &#x201C;Nigeria&#x2019;s health policy makers want to hear my opinion about how CC screening should be conducted.&#x201D;</p>
<table-wrap position="float" id="tab6">
<label>Table 6</label>
<caption>
<p>Respondent self-efficacy related to HPV screening.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top" rowspan="2">Question</th>
<th align="center" valign="top" colspan="2">Pre-deliberation</th>
<th align="center" valign="top" colspan="2">Post- deliberation</th>
<th/>
</tr>
<tr>
<th align="center" valign="top">Mean</th>
<th align="center" valign="top">SD</th>
<th align="center" valign="top">Mean</th>
<th align="center" valign="top">SD</th>
<th align="center" valign="top">Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">I am confident I can explain to members of my community how HPV influences CC risk</td>
<td align="center" valign="top">4.20</td>
<td align="center" valign="top">1.056</td>
<td align="center" valign="top">4.70</td>
<td align="center" valign="top">0.571</td>
<td align="center" valign="top">0.076</td>
</tr>
<tr>
<td align="left" valign="top">I am confident I can explain to members of my community how women can collect their own sample to be tested for HPV</td>
<td align="center" valign="top">3.84</td>
<td align="center" valign="top">1.119</td>
<td align="center" valign="top">4.58</td>
<td align="center" valign="top">0.507</td>
<td align="center" valign="top">0.007&#x002A;</td>
</tr>
<tr>
<td align="left" valign="top">I am confident I can explain to members of my community what a high-risk CC screening result means</td>
<td align="center" valign="top">4.05</td>
<td align="center" valign="top">1.129</td>
<td align="center" valign="top">4.74</td>
<td align="center" valign="top">0.452</td>
<td align="center" valign="top">0.011&#x002A;</td>
</tr>
<tr>
<td align="left" valign="top">I am confident I can explain to members of my community how often women need to get CC screening</td>
<td align="center" valign="top">4.10</td>
<td align="center" valign="top">1.119</td>
<td align="center" valign="top">4.80</td>
<td align="center" valign="top">0.410</td>
<td align="center" valign="top">0.012&#x002A;</td>
</tr>
<tr>
<td align="left" valign="top">I am confident I can explain to members of my community why WLWH are more likely to get CC</td>
<td align="center" valign="top">4.42</td>
<td align="center" valign="top">1.170</td>
<td align="center" valign="top">4.84</td>
<td align="center" valign="top">0.375</td>
<td align="center" valign="top">0.134</td>
</tr>
<tr>
<td align="left" valign="top">My opinions can influence health policy related to CC screening access in Nigeria</td>
<td align="center" valign="top">1.57</td>
<td align="center" valign="top">1.076</td>
<td align="center" valign="top">4.57</td>
<td align="center" valign="top">0.598</td>
<td align="center" valign="top">0.000&#x002A;</td>
</tr>
<tr>
<td align="left" valign="top">Nigeria&#x2019;s health policy makers want to hear my opinion about how CC screening should be conducted</td>
<td align="center" valign="top">4.00</td>
<td align="center" valign="top">0.918</td>
<td align="center" valign="top">4.50</td>
<td align="center" valign="top">0.607</td>
<td align="center" valign="top">0.038&#x002A;</td>
</tr>
<tr>
<td align="left" valign="top">Community members working together can influence Nigeria&#x2019;s health policy makers&#x2019; views on CC screening</td>
<td align="center" valign="top">4.33</td>
<td align="center" valign="top">1.017</td>
<td align="center" valign="top">4.62</td>
<td align="center" valign="top">0.590</td>
<td align="center" valign="top">0.229</td>
</tr>
<tr>
<td align="left" valign="top">My opinions are not important to Nigeria&#x2019;s health policy making related to CC screening</td>
<td align="center" valign="top">1.57</td>
<td align="center" valign="top">1.076</td>
<td align="center" valign="top">1.71</td>
<td align="center" valign="top">1.189</td>
<td align="center" valign="top">0.658</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>&#x002A;Significant at &#x03B1;&#x202F;&#x2264;&#x202F;0.05.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec22">
<label>3.4</label>
<title>Quality of the deliberation process</title>
<sec id="sec23">
<label>3.4.1</label>
<title>Speaking opportunities (inclusivity)</title>
<p>Participant speaking counts ranged from 1 comment to 63 counts of comments with a mean of 14.6 and range of percentage of participation from 3.5 to 60% of comments made within the small groups. Notably, many of the lower counts of participation included long comments versus shorter, broken up comments for the very high counts.</p>
</sec>
<sec id="sec24">
<label>3.4.2</label>
<title>Reasoned justification of ideas (consideration of balanced and factual information)</title>
<p>The quality of a deliberation is upheld when participants show a willingness to explain the rationale for their viewpoints based on the expert testimonies or the perspectives of other deliberators. In all small group discussions, participants regularly pointed to the expert testimonies to support the pros and cons they suggested. For example, one nurse participant referenced the expert testimony regarding legal requirements for disclosing health data in Nigeria saying <italic>&#x201C;Even though the video says, I agree that the Nigerian government have approved disclosing HIV by the Mentor mothers. But my argument is that HIV is not the same as HPV. HIV is not a death sentence. It&#x2019;s not something that leads to death. HPV is a cancer precursor. So it&#x2019;s a more problem.&#x201D; (Group 1, Day 2).</italic></p>
<p>Additionally, deliberators considered the viewpoints of others as they weighed the optimal choice for each question. For example, one gynecologist participating in the deliberation noted a change in his perspective from initially believing that the program should be home-based to understanding the value of the community-based intervention saying: <italic>&#x201C;The issue is that the key thing I have for option one (home-based) is confidentiality. But listening to the rest of the group, I&#x2019;m now wondering if the fact that if you put a group together that know themselves that ability to get peer support among them knowing that they all have the same thing - I&#x2019;m wondering if that will outweigh the potential confidentiality. So, I&#x2019;m veering toward saying that maybe, maybe it will outweigh the confidentiality because they are able to support themselves.&#x201D; (Day 1, Group 1).</italic></p>
</sec>
</sec>
<sec id="sec25">
<label>3.5</label>
<title>Adoption of societal perspective</title>
<p>Adopting a societal perspective was demonstrated when participants shared a perspective that valued the group welfare over their own personal interests. While there were many examples of pros and cons offered during deliberation that focused on the societal perspective, we also noted responses that clearly demonstrated a focus on improving societal welfare over one&#x2019;s personal views. For example, a participant who was a nurse in the clinics and had previously expressed concerns that nurses were being left out of the study process noted that after the deliberation <italic>&#x201C;What really made me choose option 2 (Mentor mothers returning all results) &#x2026; is the PMTCT (prevention of mother to child transmission of HIV). If we all remember the PMTCT program, it went really well. We&#x2019;ve been working with mentor mothers. We&#x2019;ve been sharing issues and deliberations together&#x2026; So, I believe these two, as we are working together with the nurses and Mentor mothers will achieve the best.&#x201D; (group 2, day 2).</italic> This statement demonstrates that although the participant was concerned about having her role as a nurse valued, she understood that having MMs return all results to the women was better for patients because of the increased level of trust between patients and MMs. Another nurse very specifically commented on the need for societal perspective during deliberation when she stated <italic>&#x201C;We&#x2019;re not talking about the material benefit. Let us talk about the benefit of the patient.&#x201D; (Group 2, day 2)</italic> Similarly, in the heat of deliberation on day 2, a nurse changed her vote to support MMs returning all results saying <italic>&#x201C;That we did not pick nurses. If I had that impression, I will vote against profession. Let us vote in the interest of our community, in the interest of public health.&#x201D; (Group 3, Day 2).</italic></p>
</sec>
<sec id="sec26">
<label>3.6</label>
<title>Deliberation day 1 results</title>
<p>Deliberators came to agreement on the first deliberation question: <italic>What is the approach for collecting HPV samples for women who are HIV+ that best balances benefits and challenges?</italic> In small group discussions, there was strong consensus that option two, having MMs provide education to WLWH in organized groups and with MMs transporting samples back to the laboratory or clinic. Multiple reasons were given for selecting the community option, including issues of transportation and peer support.</p>
<p>As one participant noted<italic>: Why I choose option two is because for the client to say to collect the sample by herself to bring it to the facility. She may tell you she do not have transport to come. Transportation. She will tell you that she do not have transportation to come (Group 1, Day 1).</italic></p>
<p>Another reason given to support the community option was the efficiency of group education. A participant who identified herself as a MM noted: <italic>When you are doing one by one, I&#x2019;ll be repeating myself. But it will be group like this one is saying organized group. Talk about what CC is, how to go about the testing. At least I am going to give them information at the same time. And all the women, if there is going to be a demonstration of how to use the kit. It will be one off and they will understand the reason why we are doing it. It&#x2019;s a group thing (Group 3, Day 1).</italic></p>
<p>Option two was ultimately selected by all four of the breakout groups. Three of the four groups reached 80% consensus in the first round of voting. The fourth group reached 80% consensus on their second round of voting. In the larger group, 100% consensus was reached in the first round of voting.</p>
</sec>
<sec id="sec27">
<label>3.7</label>
<title>Deliberation day 2 results</title>
<p>Deliberators took longer to come to agreement on the second question: <italic>What is the approach for returning results to women who are screened for HPV that best balances the benefits and challenges?</italic> With option 1 being return of HrHPV positive results by clinical staff and option 2 being return of all results by MM. Small group discussions did not come to immediate consensus. One participant noted the importance of the trust between patients and Mentor mothers saying: <italic>Patients trust Mentor Mothers more than the nurses because they believe that they are the same group. So when a mentor mother counsels a patient, the patient pays more attention than the nurse. They believe that the nurses are just there wearing white. But the mentor mother wears the same shoes as them. So, I believe they trust mentor mothers</italic> (<italic>Group 2, Day 2</italic>).</p>
<p>There was also considerable discussion about option two to train MMs with extra training to return all results (both positive and negative) to patients.</p>
<p>One participant noted that they had concerns about the ability to train MMs to deliver complex results noting: &#x201C;<italic>The cons, what, what I have against, the potential problem is that there may be difficulty with training or learning on the part of the mentor mother</italic>.&#x201D; (<italic>Group 4, Day 2</italic>).</p>
<p>In contrast, another participant stated: <italic>&#x201C;But the option here says they will be trained. and I feel there&#x2019;s really nothing rocket science in disclosing, a positive result</italic>.&#x201D; (<italic>Group 4, Day 2</italic>).</p>
<p>One group came to 80% consensus in the first round of voting; two groups came to consensus on option 2 in two rounds of voting; the final group came to consensus after three rounds of voting. The large group consensus process required three rounds of voting to reach 80% consensus. The first vote showed a score of 38.1% for option 1 and 61.9% for option 2. Similarly, there was no consensus in the second round with option 1 having 23.8%, and option 2 having 76.2%; consensus was not reached until the third round when option 1 got 19% and option 2 got 81%. Overall, the large group voted for option 2 (MMs return all results) with 81% consensus.</p>
</sec>
</sec>
<sec sec-type="discussion" id="sec28">
<label>4</label>
<title>Discussion</title>
<p>As noted above, DD should both generate more authentic community member opinions and empower community members to influence the creation of an intervention. The implementation of our DD process has been both an important intellectual exercise as well as a team-building exercise for our internal research team and community members. We found the process to be feasible and believe that the process met the standards of deliberator engagement, justified reasoning and employing a societal perspective. We also believe the experience greatly enhanced the development of our planned intervention. Yet, our use of DD in Nigeria required a number of adaptations including the need for a pre-deliberation among study team members. Additionally, as would be the case in any DD or community engaged data collection process, it is critical to pay attention to cultural norms and expectations. Therefore, all images and language used in materials or presentations were reviewed by Nigerian social scientists to ensure cultural appropriateness. Further, the expert testimony videos were recorded by a Nigerian voiceover artist (in English).</p>
<p>Our deliberation process was subject to limitations that are likely to occur when applying DD methods in Nigeria or other LMIC settings. For example, as noted above, we veered away from the gold standard DD recruitment process, which would typically include using a community-based recruitment process whereby the large population of community members would be solicited for participation subject to a recruitment rubric that focuses on diversity of participants with regards to both demographic factors and viewpoints. In our situation, as may be the case in other LMIC settings, in-country researchers felt it was necessary to include specific individuals for the purpose of building support of the intervention that would be developed from the DD process. Additionally, while we captured 8 of the 10 perspectives our team identified as important for the deliberation, we were not able to include husbands or community members not living with HIV, finding people with these perspectives difficult to recruit. These perspectives might have increased the diversity of pros and cons from the process.</p>
<p>Notably, the DD process is resource intensive, especially if one is seeking geographic diversity in a large country like Nigeria. Many of our deliberation participants traveled to Lagos from elsewhere in the country, which required time and financial resources. When there is a need to include specific individuals who represent a certain viewpoint, some of which may be prominent stakeholders, significant planning is required to ensure their availability to participate. Those seeking to use a DD process in LMIC settings should weigh the resources required, the political implications and adaptations needed in the specific location with the likely impact of the data collected. In the case of our study, we believe the consensus reached regarding HPV screening helped restructure our innovation in a way that is likely to increase effectiveness of the program but the resource-intensive nature could limit feasibility in some circumstances.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec29">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, to the extent that data can be deidentified, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="sec30">
<title>Ethics statement</title>
<p>The ethics committee/institutional review board waived the requirement of written informed consent for participants in the stakeholder deliberations because the research only involved professionals in their professional capacities. Written consent was obtained for women living with HIV enrolled in the CHESS study as participants.</p>
</sec>
<sec sec-type="author-contributions" id="sec31">
<title>Author contributions</title>
<p>LG: Conceptualization, Formal analysis, Funding acquisition, Methodology, Supervision, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. KS: Conceptualization, Investigation, Methodology, Writing &#x2013; review &#x0026; editing. WY: Formal analysis, Investigation, Writing &#x2013; review &#x0026; editing. II: Conceptualization, Investigation, Writing &#x2013; review &#x0026; editing. OAw: Conceptualization, Funding acquisition, Investigation, Writing &#x2013; review &#x0026; editing. OO: Conceptualization, Funding acquisition, Investigation, Writing &#x2013; review &#x0026; editing. TS: Investigation, Project administration, Supervision, Writing &#x2013; review &#x0026; editing. PE: Investigation, Writing &#x2013; review &#x0026; editing. OAj: Writing &#x2013; review &#x0026; editing. OE: Funding acquisition, Supervision, Writing &#x2013; review &#x0026; editing. CM: Conceptualization, Investigation, Methodology, Supervision, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. LF: Conceptualization, Funding acquisition, Investigation, Methodology, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="funding-information" id="sec32">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This peer-reviewed study is funded by National Cancer Institute under the U01 Cooperative agreement U01CA275113&#x2013;01 (MPIs- Lisa Flowers, Laura Gaydos, Olutosin Awolude, Oliver Ezechi. Olabanjo Ogunsola).</p>
</sec>
<ack>
<p>We thank Treasure Ebikwo for her assistance editing the manuscript. We also thank Foluso Balogun and Aisha Gambari for their assistance conducting the deliberations in Nigeria.</p>
</ack>
<sec sec-type="COI-statement" id="sec33">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="sec34">
<title>Generative AI statement</title>
<p>The authors declare that no Gen AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="sec35">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr">
<p>CC, Cervical cancer; CHESS, Community Home Based Education Screening Services; HCC, HPV cervical cancer screening; HPV, Human Papillomavirus; hrHPV, High risk human papillomavirus; LMICs, Low- and Middle-Income Countries; MM, Mentor mothers; SC, Self-collected; SD, Stakeholder deliberation; WLWH, Women Living with HIV.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barker</surname><given-names>PM</given-names></name> <name><surname>Reid</surname><given-names>A</given-names></name> <name><surname>Schall</surname><given-names>MW</given-names></name></person-group>. <article-title>A framework for scaling up health interventions: lessons from large-scale improvement initiatives in Africa</article-title>. <source>Implement Sci</source>. (<year>2015</year>) <volume>11</volume>:<fpage>1</fpage>&#x2013;<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.1186/s13012-016-0374-x</pub-id>, PMID: <pub-id pub-id-type="pmid">26821910</pub-id></citation></ref>
<ref id="ref2"><label>2.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yapa</surname><given-names>HM</given-names></name> <name><surname>B&#x00E4;rnighausen</surname><given-names>T</given-names></name></person-group>. <article-title>Implementation science in resource-poor countries and communities</article-title>. <source>Implement Sci</source>. (<year>2018</year>) <volume>13</volume>:<fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.1186/s13012-018-0847-1</pub-id>, PMID: <pub-id pub-id-type="pmid">30587195</pub-id></citation></ref>
<ref id="ref3"><label>3.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rifkin</surname><given-names>SB</given-names></name></person-group>. <article-title>Examining the links between community participation and health outcomes: a review of the literature</article-title>. <source>Health Policy Plan</source>. (<year>2014</year>) <volume>29</volume>:<fpage>ii98</fpage>&#x2013;<lpage>ii106</lpage>. doi: <pub-id pub-id-type="doi">10.1093/heapol/czu076</pub-id>, PMID: <pub-id pub-id-type="pmid">25274645</pub-id></citation></ref>
<ref id="ref4"><label>4.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>George</surname><given-names>AS</given-names></name> <name><surname>Mehra</surname><given-names>V</given-names></name> <name><surname>Scott</surname><given-names>K</given-names></name> <name><surname>Sriram</surname><given-names>V</given-names></name></person-group>. <article-title>Community participation in health systems research: a systematic review assessing the state of research, the nature of interventions involved and the features of engagement with communities</article-title>. <source>PLoS One</source>. (<year>2015</year>) <volume>10</volume>:<fpage>e0141091</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0141091</pub-id>, PMID: <pub-id pub-id-type="pmid">26496124</pub-id></citation></ref>
<ref id="ref5"><label>5.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sam-Agudu</surname><given-names>NA</given-names></name> <name><surname>Ramadhani</surname><given-names>HO</given-names></name> <name><surname>Isah</surname><given-names>C</given-names></name> <name><surname>Anaba</surname><given-names>U</given-names></name> <name><surname>Erekaha</surname><given-names>S</given-names></name> <name><surname>Fan-Osuala</surname><given-names>C</given-names></name> <etal/></person-group>. <article-title>The impact of structured mentor mother programs on 6-month postpartum retention and viral suppression among HIV-positive women in rural Nigeria: a prospective paired cohort study</article-title>. <source>J Acquir Immune Defic Syndr</source>. (<year>2017</year>) <volume>75</volume>:<fpage>S173</fpage>&#x2013;<lpage>81</lpage>. doi: <pub-id pub-id-type="doi">10.1097/QAI.0000000000001346</pub-id>, PMID: <pub-id pub-id-type="pmid">28498187</pub-id></citation></ref>
<ref id="ref6"><label>6.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>L</given-names></name> <name><surname>Rotheram-Borus</surname><given-names>MJ</given-names></name> <name><surname>Van Heerden</surname><given-names>A</given-names></name> <name><surname>Stein</surname><given-names>A</given-names></name> <name><surname>Tomlinson</surname><given-names>M</given-names></name> <name><surname>Harwood</surname><given-names>JM</given-names></name> <etal/></person-group>. <article-title>Pregnant women living with HIV (WLH) supported at clinics by peer WLH: A cluster randomized controlled trial</article-title>. <source>AIDS Behav</source>. (<year>2014</year>) <volume>18</volume>:<fpage>706</fpage>&#x2013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10461-014-0694-2</pub-id>, PMID: <pub-id pub-id-type="pmid">24469222</pub-id></citation></ref>
<ref id="ref7"><label>7.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Denny</surname><given-names>L</given-names></name></person-group>. <article-title>The prevention of cervical cancer in developing countries</article-title>. <source>BJOG Int J Obstet Gynaecol</source>. (<year>2005</year>) <volume>112</volume>:<fpage>1204</fpage>&#x2013;<lpage>12</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1471-0528.2005.00713.x</pub-id>, PMID: <pub-id pub-id-type="pmid">16101597</pub-id></citation></ref>
<ref id="ref8"><label>8.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>H</given-names></name> <name><surname>Weiss</surname><given-names>HA</given-names></name> <name><surname>Benavente</surname><given-names>Y</given-names></name> <name><surname>de Sanjose</surname><given-names>S</given-names></name> <name><surname>Mayaud</surname><given-names>P</given-names></name> <name><surname>Qiao</surname><given-names>Y-l</given-names></name> <etal/></person-group>. <article-title>Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis</article-title>. <source>Lancet HIV</source>. (<year>2018</year>) <volume>5</volume>:<fpage>e45</fpage>&#x2013;<lpage>58</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S2352-3018(17)30149-2</pub-id>, PMID: <pub-id pub-id-type="pmid">29107561</pub-id></citation></ref>
<ref id="ref9"><label>9.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zehbe</surname><given-names>I</given-names></name> <name><surname>Jackson</surname><given-names>R</given-names></name> <name><surname>Wood</surname><given-names>B</given-names></name> <name><surname>Weaver</surname><given-names>B</given-names></name> <name><surname>Escott</surname><given-names>N</given-names></name> <name><surname>Severini</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>Community-randomised controlled trial embedded in the Anishinaabek cervical Cancer screening study: human papillomavirus self-sampling versus Papanicolaou cytology</article-title>. <source>BMJ Open</source>. (<year>2016</year>) <volume>6</volume>:<fpage>e011754</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmjopen-2016-011754</pub-id>, PMID: <pub-id pub-id-type="pmid">27855089</pub-id></citation></ref>
<ref id="ref10"><label>10.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castle</surname><given-names>PE</given-names></name></person-group>. <article-title>When less is more</article-title>. <source>J Natl Cancer Inst</source>. (<year>2017</year>) <volume>109</volume>:<fpage>djw240</fpage>. doi: <pub-id pub-id-type="doi">10.1093/jnci/djw240</pub-id>, PMID: <pub-id pub-id-type="pmid">27756809</pub-id></citation></ref>
<ref id="ref11"><label>11.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khozaim</surname><given-names>K</given-names></name> <name><surname>Orang&#x2019;o</surname><given-names>E</given-names></name> <name><surname>Christoffersen-Deb</surname><given-names>A</given-names></name> <name><surname>Itsura</surname><given-names>P</given-names></name> <name><surname>Oguda</surname><given-names>J</given-names></name> <name><surname>Muliro</surname><given-names>H</given-names></name> <etal/></person-group>. <article-title>Successes and challenges of establishing a cervical cancer screening and treatment program in western Kenya</article-title>. <source>Int J Gynaecol Obstet</source>. (<year>2014</year>) <volume>124</volume>:<fpage>12</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijgo.2013.06.035</pub-id>, PMID: <pub-id pub-id-type="pmid">24140218</pub-id></citation></ref>
<ref id="ref12"><label>12.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alfaro</surname><given-names>K</given-names></name> <name><surname>Soler</surname><given-names>M</given-names></name> <name><surname>Maza</surname><given-names>M</given-names></name> <name><surname>Flores</surname><given-names>M</given-names></name> <name><surname>L&#x00F3;pez</surname><given-names>L</given-names></name> <name><surname>Rauda</surname><given-names>JC</given-names></name> <etal/></person-group>. <article-title>Cervical Cancer prevention in El Salvador: gains to date and challenges for the future</article-title>. <source>Cancers (Basel)</source>. (<year>2022</year>) <volume>14</volume>:<fpage>776</fpage>. doi: <pub-id pub-id-type="doi">10.3390/cancers14112776</pub-id>, PMID: <pub-id pub-id-type="pmid">35681756</pub-id></citation></ref>
<ref id="ref13"><label>13.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Afolabi</surname><given-names>BB</given-names></name> <name><surname>Ayinde</surname><given-names>OA</given-names></name> <name><surname>Bamgboye</surname><given-names>EA</given-names></name></person-group>. <article-title>Knowledge attitudes and practices of cervical cancer screening among urban and rural Nigerian women: a call for education and mass screening</article-title>. <source>Eur J Cancer Care (Engl)</source>. (<year>2020</year>) <volume>20</volume>:<fpage>362</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2354.2009.01175.x</pub-id>, PMID: <pub-id pub-id-type="pmid">20345451</pub-id></citation></ref>
<ref id="ref14"><label>14.</label> <citation citation-type="book"><person-group person-group-type="author"><name><surname>Popay</surname><given-names>J</given-names></name> <name><surname>Attree</surname><given-names>P</given-names></name> <name><surname>Hornby</surname><given-names>D</given-names></name> <name><surname>Milton</surname><given-names>B</given-names></name> <name><surname>Whitehead</surname><given-names>M</given-names></name> <name><surname>French</surname><given-names>B</given-names></name> <etal/></person-group>. <source>Community engagement in initiatives addressing the wider social determinants of health: a rapid review of evidence on impact, experience and process</source>. <publisher-loc>Lancaster</publisher-loc>: <publisher-name>University of Lancaster</publisher-name> (<year>2007</year>).</citation></ref>
<ref id="ref15"><label>15.</label> <citation citation-type="other"><person-group person-group-type="author"><name><surname>Popay</surname><given-names>J</given-names></name></person-group>. <italic>Guidance on the conduct of narrative synthesis in systematic reviews</italic>. ESRC methods programme. (<year>2006</year>).</citation></ref>
<ref id="ref16"><label>16.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>Y</given-names></name> <name><surname>Pathak</surname><given-names>S</given-names></name> <name><surname>Ballard</surname><given-names>D</given-names></name> <name><surname>Veluswamy</surname><given-names>J</given-names></name> <name><surname>McCullough</surname><given-names>LE</given-names></name> <name><surname>McBride</surname><given-names>CM</given-names></name> <etal/></person-group>. <article-title>Testing a deliberative democracy method with citizens of African ancestry to weigh pros and cons of targeted screening for hereditary breast and ovarian cancer risk</article-title>. <source>Front Public Health</source>. (<year>2022</year>) <volume>10</volume>:<fpage>984926</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpubh.2022.984926</pub-id>, PMID: <pub-id pub-id-type="pmid">36424974</pub-id></citation></ref>
<ref id="ref17"><label>17.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Street</surname><given-names>J</given-names></name> <name><surname>Duszynski</surname><given-names>K</given-names></name> <name><surname>Krawczyk</surname><given-names>S</given-names></name> <name><surname>Braunack-Mayer</surname><given-names>A</given-names></name></person-group>. <article-title>The use of citizens' juries in health policy decision-making: a systematic review</article-title>. <source>Soc Sci Med</source>. (<year>2014</year>) <volume>109</volume>:<fpage>1</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.socscimed.2014.03.005</pub-id>, PMID: <pub-id pub-id-type="pmid">24657639</pub-id></citation></ref>
<ref id="ref18"><label>18.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Degeling</surname><given-names>C</given-names></name> <name><surname>Carter</surname><given-names>SM</given-names></name> <name><surname>Rychetnik</surname><given-names>L</given-names></name></person-group>. <article-title>Which public and why deliberate?&#x2013;A scoping review of public deliberation in public health and health policy research</article-title>. <source>Soc Sci Med</source>. (<year>2015</year>) <volume>131</volume>:<fpage>114</fpage>&#x2013;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.socscimed.2015.03.009</pub-id>, PMID: <pub-id pub-id-type="pmid">25770463</pub-id></citation></ref>
<ref id="ref19"><label>19.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tromp</surname><given-names>N</given-names></name> <name><surname>Prawiranegara</surname><given-names>R</given-names></name> <name><surname>Siregar</surname><given-names>A</given-names></name> <name><surname>Wisaksana</surname><given-names>R</given-names></name> <name><surname>Pinxten</surname><given-names>L</given-names></name> <name><surname>Pinxten</surname><given-names>J</given-names></name> <etal/></person-group>. <article-title>Translating international HIV treatment guidelines into local priorities in Indonesia</article-title>. <source>Trop Med Int Health</source>. (<year>2018</year>) <volume>23</volume>:<fpage>279</fpage>&#x2013;<lpage>94</lpage>. doi: <pub-id pub-id-type="doi">10.1111/tmi.13031</pub-id>, PMID: <pub-id pub-id-type="pmid">29327397</pub-id></citation></ref>
<ref id="ref20"><label>20.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thaldar</surname><given-names>D</given-names></name> <name><surname>Shozi</surname><given-names>B</given-names></name> <name><surname>Steytler</surname><given-names>M</given-names></name> <name><surname>Hendry</surname><given-names>G</given-names></name> <name><surname>Botes</surname><given-names>M</given-names></name> <name><surname>Mnyandu</surname><given-names>N</given-names></name> <etal/></person-group>. <article-title>A deliberative public engagement study on heritable human genome editing among south Africans: study results</article-title>. <source>PLoS One</source>. (<year>2022</year>) <volume>17</volume>:<fpage>e0275372</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0275372</pub-id>, PMID: <pub-id pub-id-type="pmid">36441783</pub-id></citation></ref>
<ref id="ref21"><label>21.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wanjau</surname><given-names>MN</given-names></name> <name><surname>Kivuti-Bitok</surname><given-names>LW</given-names></name> <name><surname>Aminde</surname><given-names>LN</given-names></name> <name><surname>Veerman</surname><given-names>L</given-names></name></person-group>. <article-title>Stakeholder perceptions of current practices and challenges in priority setting for non-communicable disease control in Kenya: a qualitative study</article-title>. <source>BMJ Open</source>. (<year>2021</year>) <volume>11</volume>:<fpage>e043641</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmjopen-2020-043641</pub-id>, PMID: <pub-id pub-id-type="pmid">33795302</pub-id></citation></ref>
<ref id="ref22"><label>22.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tugendhaft</surname><given-names>A</given-names></name> <name><surname>Hofman</surname><given-names>K</given-names></name> <name><surname>Danis</surname><given-names>M</given-names></name> <name><surname>Kahn</surname><given-names>K</given-names></name> <name><surname>Erzse</surname><given-names>A</given-names></name> <name><surname>Twine</surname><given-names>R</given-names></name> <etal/></person-group>. <article-title>Deliberative engagement methods on health care priority-setting in a rural south African community</article-title>. <source>Health Policy Plan</source>. (<year>2021</year>) <volume>36</volume>:<fpage>1279</fpage>&#x2013;<lpage>91</lpage>. doi: <pub-id pub-id-type="doi">10.1093/heapol/czab005</pub-id>, PMID: <pub-id pub-id-type="pmid">34051093</pub-id></citation></ref>
<ref id="ref23"><label>23.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kanters</surname><given-names>S</given-names></name> <name><surname>Park</surname><given-names>JJ</given-names></name> <name><surname>Chan</surname><given-names>K</given-names></name> <name><surname>Ford</surname><given-names>N</given-names></name> <name><surname>Forrest</surname><given-names>J</given-names></name> <name><surname>Thorlund</surname><given-names>K</given-names></name> <etal/></person-group>. <article-title>Use of peers to improve adherence to antiretroviral therapy: a global network meta-analysis</article-title>. <source>J Int AIDS Soc</source>. (<year>2016</year>) <volume>19</volume>:<fpage>21141</fpage>. doi: <pub-id pub-id-type="doi">10.7448/IAS.19.1.21141</pub-id>, PMID: <pub-id pub-id-type="pmid">27914185</pub-id></citation></ref>
<ref id="ref24"><label>24.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rotheram-Borus</surname><given-names>MJ</given-names></name> <name><surname>Richter</surname><given-names>LM</given-names></name> <name><surname>van Heerden</surname><given-names>A</given-names></name> <name><surname>van Rooyen</surname><given-names>H</given-names></name> <name><surname>Tomlinson</surname><given-names>M</given-names></name> <name><surname>Harwood</surname><given-names>JM</given-names></name> <etal/></person-group>. <article-title>A cluster randomized controlled trial evaluating the efficacy of peer mentors to support south African women living with HIV and their infants</article-title>. <source>PLoS One</source>. (<year>2014</year>) <volume>9</volume>:<fpage>e84867</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0084867</pub-id>, PMID: <pub-id pub-id-type="pmid">24465444</pub-id></citation></ref>
<ref id="ref25"><label>25.</label> <citation citation-type="book"><person-group person-group-type="author"><name><surname>Olson</surname><given-names>K.</given-names></name></person-group> <source>Deliberative democracy</source>. <publisher-loc>Abingdon</publisher-loc>: <publisher-name>Routledge</publisher-name>, pp. <fpage>140</fpage>&#x2013;<lpage>155</lpage>. (<year>2014</year>).</citation></ref>
<ref id="ref26"><label>26.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baltussen</surname><given-names>R</given-names></name> <name><surname>Jansen</surname><given-names>MP</given-names></name> <name><surname>Mikkelsen</surname><given-names>E</given-names></name> <name><surname>Tromp</surname><given-names>N</given-names></name> <name><surname>Hontelez</surname><given-names>J</given-names></name> <name><surname>Bijlmakers</surname><given-names>L</given-names></name> <etal/></person-group>. <article-title>Priority setting for universal health coverage: we need evidence-informed deliberative processes, not just more evidence on cost-effectiveness</article-title>. <source>Int J Health Policy Manag</source>. (<year>2016</year>) <volume>5</volume>:<fpage>615</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.15171/ijhpm.2016.83</pub-id>, PMID: <pub-id pub-id-type="pmid">27801355</pub-id></citation></ref>
<ref id="ref27"><label>27.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>G</given-names></name> <name><surname>Wales</surname><given-names>C</given-names></name></person-group>. <article-title>Citizens' juries and deliberative democracy</article-title>. <source>Polit Stud</source>. (<year>2000</year>) <volume>48</volume>:<fpage>51</fpage>&#x2013;<lpage>65</lpage>. doi: <pub-id pub-id-type="doi">10.1111/1467-9248.00250</pub-id></citation></ref>
<ref id="ref28"><label>28.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>O'Doherty</surname><given-names>KC</given-names></name> <name><surname>Hawkins</surname><given-names>AK</given-names></name> <name><surname>Burgess</surname><given-names>MM</given-names></name></person-group>. <article-title>Involving citizens in the ethics of biobank research: informing institutional policy through structured public deliberation</article-title>. <source>Soc Sci Med</source>. (<year>2012</year>) <volume>75</volume>:<fpage>1604</fpage>&#x2013;<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.socscimed.2012.06.026</pub-id>, PMID: <pub-id pub-id-type="pmid">22867865</pub-id></citation></ref>
<ref id="ref29"><label>29.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x2019;Doherty</surname><given-names>KC</given-names></name> <name><surname>Burgess</surname><given-names>MM</given-names></name> <name><surname>Edwards</surname><given-names>K</given-names></name> <name><surname>Gallagher</surname><given-names>RP</given-names></name> <name><surname>Hawkins</surname><given-names>AK</given-names></name> <name><surname>Kaye</surname><given-names>J</given-names></name> <etal/></person-group>. <article-title>From consent to institutions: designing adaptive governance for genomic biobanks</article-title>. <source>Soc Sci Med</source>. (<year>2011</year>) <volume>73</volume>:<fpage>367</fpage>&#x2013;<lpage>74</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.socscimed.2011.05.046</pub-id>, PMID: <pub-id pub-id-type="pmid">21726926</pub-id></citation></ref>
<ref id="ref30"><label>30.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulumba</surname><given-names>M</given-names></name> <name><surname>Ruano</surname><given-names>AL</given-names></name> <name><surname>Perehudoff</surname><given-names>K</given-names></name> <name><surname>Ooms</surname><given-names>G</given-names></name></person-group>. <article-title>Decolonizing health governance: a Uganda case study on the influence of political history on community participation</article-title>. <source>Health Hum Rights</source>. (<year>2021</year>) <volume>23</volume>:<fpage>259</fpage>. PMID: <pub-id pub-id-type="pmid">34194218</pub-id></citation></ref>
<ref id="ref31"><label>31.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raisio</surname><given-names>H</given-names></name></person-group>. <article-title>The public as policy expert: deliberative democracy in the context of Finnish health care reforms and policies</article-title>. <source>J Deliberative Democ</source>. (<year>2010</year>) <volume>6</volume>:<fpage>11</fpage>. doi: <pub-id pub-id-type="doi">10.16997/jdd.111</pub-id></citation></ref>
<ref id="ref32"><label>32.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Springett</surname><given-names>J</given-names></name></person-group>. <article-title>Integrating values research and knowledge development through the use of participatory evaluation in community based health promotion</article-title>. <source>Estud Sobre Cult Contemp</source>. (<year>2010</year>) <volume>16</volume>:<fpage>277</fpage>&#x2013;<lpage>97</lpage>.</citation></ref>
<ref id="ref33"><label>33.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dale</surname><given-names>E</given-names></name> <name><surname>Peacocke</surname><given-names>EF</given-names></name> <name><surname>Movik</surname><given-names>E</given-names></name> <name><surname>Voorhoeve</surname><given-names>A</given-names></name> <name><surname>Ottersen</surname><given-names>T</given-names></name> <name><surname>Kurowski</surname><given-names>C</given-names></name> <etal/></person-group>. <article-title>Criteria for the procedural fairness of health financing decisions: a scoping review</article-title>. <source>Health Policy Plann</source>. (<year>2023</year>) <volume>38</volume>:<fpage>i13</fpage>. doi: <pub-id pub-id-type="doi">10.1093/heapol/czad066</pub-id>, PMID: <pub-id pub-id-type="pmid">37963078</pub-id></citation></ref>
</ref-list>
</back>
</article>